Combinations of riluzole and levodopa for the treatment of Parkinson's disease
AssigneeAventis Pharma S.A.
InventorsVéronique Blanchard-Bregeon, Assunta Imperato, Saliha Moussaoui, Marie-Carmen Obinu, Michel Reibaud
Life of this patent
Estimating the term…
Abstract
The invention concerns a combination of levodopa and riluzole or a pharmaceutically acceptable salt of said compound and the use of said combination for treating Parkinson Disease.
Claims20
A pharmaceutical composition comprising a combination of levodopa and riluzole or a pharmaceutically acceptable salt thereof.
A pharmaceutical compositions comprising riluzole useful as a medicament in the prevention and treatment of dyskinesias induced by levodopa.
A method of treating Parkinson's disease comprising administering to a patient in need thereof an effective amount of riluzole or a pharmaceutically acceptable salt thereof in combination with levodopa, optionally in combination with the pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.